Obviously, not only the passive tumor accumulation derived from the enhanced permeation and retention effect31, but also the scAb-EGFR-mediated active targeting contributed significantly to the remarkable tumor accumulation of HCC-targeting nanomedicines in the liver orthotropic HCC xenograft models. Here, EGFR is linked to hepatocellular carcinoma.